#None #Marseille #Terumo Neuro #Aneurysm Treatment #EMEA Initiative

Introduction

Terumo Neuro has announced the establishment of the Aneurysm Treatment Alliance, a new initiative aimed at enhancing collaboration among medical professionals and spotlighting its diverse portfolio for aneurysm treatment across the EMEA (Europe, the Middle East, and Africa) region. This announcement was made during the European Society of Minimally Invasive Neurological Therapy (ESMINT) Annual Congress 2025 held in Marseille, France.

Objectives of the Aneurysm Treatment Alliance

The Alliance is dedicated to improving how doctors collaborate in their treatment approaches and providing comprehensive tools to ensure patient care is at its best. With a focus on sharing knowledge and clinical expertise across borders, the initiative is expected to make significant strides in how aneurysms are treated throughout the region.

Access to Terumo Neuro’s Comprehensive Portfolio

The Alliance will highlight key products that have been developed to effectively treat hemorrhages, including:

• - WEB™ Device: An innovative solution designed for the treatment of wide-necked aneurysms.
• - LVIS™ EVO™ Stents: These stents support the treatment of aneurysms with excellent flexibility and performance.
• - FRED™ X Flow Diverters: A newer addition that enhances flow dynamics during aneurysm treatment.
• - Hydrogel Coils & Bare Platinum Coils: Introduced to provide varied treatment options depending on the clinical situation.

This extensive portfolio underlines Terumo Neuro's commitment to providing innovative medical solutions that focus on enhancing clinical outcomes for patients.

Promoting Doctor Collaboration

A key aspect of the Alliance is improving collaboration among healthcare professionals. This involves moving beyond traditional presentations to foster deep, meaningful exchanges of clinical insights. By encouraging ongoing discussions and shared learning experiences, the initiative aims to drive clinical progress in aneurysm treatments.

Cross-Regional Learning Opportunities

Another exciting component of this program is the focus on cross-regional learning. The initiative will promote knowledge exchange regarding best practices in aneurysm treatment across the diverse EMEA landscape. The aim is to enhance consistency and quality in physician engagement and ultimately in patient outcomes.

Enhancing Awareness of Integrated Solutions

The Aneurysm Treatment Alliance also aims to expand awareness and education surrounding integrated implantable device solutions for aneurysm therapy. This initiative recognizes the necessity for comprehensive education on available treatment options to better inform healthcare teams, enhancing their ability to provide optimal care.

Conclusion

Sebastien Chabeauti, Vice President and General Manager, EMEA at Terumo Neuro, emphasizes that their hemorrhage portfolio is at the forefront of delivering innovative solutions grounded in strong clinical results, allowing physicians to treat a wide variety of aneurysms safely. The Aneurysm Treatment Alliance aims to bring this mission to life, equipping healthcare professionals in the EMEA with practical collaboration tools to elevate the standard of aneurysm treatment. This initiative not only reflects Terumo Neuro's vision for practical medical partnerships but also highlights the company's continuous commitment to innovation and improving patient outcomes across the globe.

For more detailed information about Terumo Neuro and its offerings, please visit www.terumoneuro.com.